As a result of SeeAbility’s campaigning, NHS England are planning for a new national programme of sight tests and glasses dispensing in England’s special schools from 2020. SeeAbility’s model of sight testing is less stressful for children with learning disabilities...
This is a large case series of orbital Schwannomas managed at a single centre over a 26-year period. Twenty Schwannomas are reported, all but one of which was managed surgically. The tumours were all benign, had an insidious onset and...
Central retinal artery occlusion (CRAO) is a rare but devastating vascular episode that can have severe impact on vision. Treatment is very time-limited and needs to be initiated very quickly to salvage any vision. The majority of patients present to...
With the 2006 Collaborative Ocular Melanoma Study Group (COMS) study demonstrating no difference in survival outcomes for participants randomised to either iodine-125 brachytherapy or enucleation, the majority of primary uveal melanomas in the United States are now treated with brachytherapy....
This is a multicentre randomised controlled trial of 22 patients with primary angle closure glaucoma with peripheral anterior synechia and peripheral primary angle closure glaucoma (PACG) with peripheral anterior synechia (PAS) detected by indentation gonioscopy was randomised into two groups....
Glaucoma UK is a leading charity dedicated to supporting those affected by glaucoma. The charity is proud to announce the establishment of the Pitts Crick Career Development Fellowship, a three-year post-doctoral research fellowship awarded to help mark the charity’s golden jubilee anniversary. The fellowship will support a rising star within glaucoma research, who the charity hopes will go on to play a pivotal role in transforming glaucoma diagnosis or treatment into the future.
The authors examined 50 untreated open angle glaucoma patients to determine if there was an association between the level of glaucomatous damage and documented risk factors. In this study the authors measured the extent of morphologic and functional glaucomatous damage...
SightCare, the business support community for independent practices, was held on 29 and 30 January 2023 after its postponement from its original September date which unfortunately fell on the day of the Queen’s funeral.
A round-up of the eye-related hot topics that have been trending on social media over the last few weeks. #algae #optogenetics Scientists in Paris have used optogenetics to partially restore sight in a blind man’s eye who was diagnosed with...
2 August 2022
| Muzammil A Nahaboo Solim, Mike McKenna, Gar-Yun Wong, Sreekumari Pushpoth, David EJ Whitehead
|
Ophthalmology, Orbit
Injuries to the eye have been widely reported in medical literature due to a variety of mechanisms causing significant morbidity and occasional unexpected mortality for the patient [1]. It is often wrongly assumed that air gun pellets lack this potential....
Central serous chorioretinopathy (CSCR) is a common retinal disease characterised by one or more serous neurosensory detachments. Patients present with acute onset blurring of vision, metamorphopsia and / or central scotomas. The condition is six times more common in men...
This is a review paper in which the authors summarise the transitioning of techniques detecting apoptosis from bench to bedside, along with the future possibilities they encase. Detection of Apoptosis in Retinal Cells (DARC) technology can be used as a...